Infliximab in Tanzania: NEMLIT level, who can prescribe it and STG references
Infliximab is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 2 sections.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is infliximab available on the DukaDawa pharmacy network?
Not yet. Infliximab is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is infliximab on the NEMLIT, and who can prescribe it?
Yes. Infliximab is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.
- Level
- S (zonal, special and national hospitals)
- Category
- Drugs affecting Intestinal Secretion and Antispasmodics (Gastro-Intestinal Medicines)
- Listed forms
- Injection 100mg (Special permit)
- Page
- NEMLIT, p. 22
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is infliximab in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention infliximab in 2 sections, most often section 10.3.1.2 Diseases of the Intestine > Inflammatory Bowel Diseases > Crohn’s Disease (p. 239). See the STG for treatment details.
- 10.3.1.2 Diseases of the Intestine > Inflammatory Bowel Diseases > Crohn’s Disease, p. 239
- 10.3.1.1 Diseases of the Intestine > Inflammatory Bowel Diseases > Ulcerative Colitis (UC), p. 239
Sections that mention Infliximab, most mentions first. Positions only: see the STG for treatment details.
Related medicines
- CholestyramineNEMLIT A, S · Not on the DukaDawa network yet
- Hyoscine butyl bromideNEMLIT B · Not on the DukaDawa network yet
- MebeverineNEMLIT D · Not on the DukaDawa network yet
- Ursodeoxycholic acidNEMLIT S · Not on the DukaDawa network yet
All drugs affecting intestinal secretion and antispasmodics on the NEMLIT
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.